Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reha-Baris Incesu

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Japanese Journal of Clinical Oncology|February 18, 2024
A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancerReha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
World Journal of Urology|September 27, 2023
Regional differences in clear cell metastatic renal cell carcinoma patients across the USALukas Scheipner, Stefano Tappero, Mattia Luca Piccinelli, et al.
Urologic Oncology|March 7, 2023
Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder CancerStefano Tappero, Francesco Barletta, Mattia Luca Piccinelli, et al.
Surgical Oncology|February 15, 2024
Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched studyCarolin Siech, Reha-Baris Incesu, Simone Morra, et al.
Surgical Oncology|April 14, 2024
Surgically treated pelvic liposarcoma and leiomyosarcoma: The effect of tumor size on cancer-specific survivalAndrea Baudo, Mattia Luca Piccinelli, Reha-Baris Incesu, et al.
Journal of Surgical Oncology|March 12, 2024
Identifying low cancer-specific mortality risk lymph node-positive radical prostatectomy patientsFrancesco Barletta, Stefano Tappero, Simone Morra, et al.
European Urology Open Science|July 13, 2023
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell CarcinomaMattia L Piccinelli, Stefano Tappero, Cristina Cano Garcia, et al.
European Urology Focus|April 6, 2023
Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality-free Survival in Surgically Treated Papillary Renal Cell Carcinoma PatientsMattia Luca Piccinelli, Francesco Barletta, Stefano Tappero, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 10, 2025
Impact of ISUP grade group on cancer-specific mortality in radical prostatectomy-treated prostate cancer patients with organ-confined diseaseFrancesco Barletta, Stefano Tappero, Simone Morra, et al.
Scientific Reports|January 6, 2025
Use of inpatient palliative care in metastatic testicular cancer patients undergoing critical care therapy: insights from the national inpatient sampleCristina Cano Garcia, Reha-Baris Incesu, Francesco Barletta, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Japanese Journal of Clinical Oncology|February 18, 2024
A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancerReha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
World Journal of Urology|September 27, 2023
Regional differences in clear cell metastatic renal cell carcinoma patients across the USALukas Scheipner, Stefano Tappero, Mattia Luca Piccinelli, et al.
Urologic Oncology|March 7, 2023
Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder CancerStefano Tappero, Francesco Barletta, Mattia Luca Piccinelli, et al.
Surgical Oncology|February 15, 2024
Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched studyCarolin Siech, Reha-Baris Incesu, Simone Morra, et al.
Surgical Oncology|April 14, 2024
Surgically treated pelvic liposarcoma and leiomyosarcoma: The effect of tumor size on cancer-specific survivalAndrea Baudo, Mattia Luca Piccinelli, Reha-Baris Incesu, et al.
Journal of Surgical Oncology|March 12, 2024
Identifying low cancer-specific mortality risk lymph node-positive radical prostatectomy patientsFrancesco Barletta, Stefano Tappero, Simone Morra, et al.
European Urology Open Science|July 13, 2023
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell CarcinomaMattia L Piccinelli, Stefano Tappero, Cristina Cano Garcia, et al.
European Urology Focus|April 6, 2023
Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality-free Survival in Surgically Treated Papillary Renal Cell Carcinoma PatientsMattia Luca Piccinelli, Francesco Barletta, Stefano Tappero, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 10, 2025
Impact of ISUP grade group on cancer-specific mortality in radical prostatectomy-treated prostate cancer patients with organ-confined diseaseFrancesco Barletta, Stefano Tappero, Simone Morra, et al.
Scientific Reports|January 6, 2025
Use of inpatient palliative care in metastatic testicular cancer patients undergoing critical care therapy: insights from the national inpatient sampleCristina Cano Garcia, Reha-Baris Incesu, Francesco Barletta, et al.
Pageof 7